SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indrayani Biotech informs about newspaper publications

15 Dec 2025 Evaluate

Pursuant to the Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indrayani Biotech has informed that it enclosed copy of newspaper publications pertaining to Unaudited Financial Results (Standalone and Consolidated) for the Quarter and half year ended September 30, 2025 published in Trinity Mirror in English Language and Makkal Kural in Tamil Language on December 13, 2025.

The above information is a part of company’s filings submitted to BSE.


Indrayani Biotech Share Price

12.08 0.00 (0.00%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Grasim Industries 2777.75
DCM Shriram 1200.00
3M India 31548.55
Hindustan Foods 496.85
Balmer Lawrie & Co 177.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×